FDA Clearance for 23andMe genetic test on Hereditary Prostate Cancer Marker
The clearance allows 23andMe to report on the G84E mutation in the HOXB13 gene, cli…
Author: Digital Health Global
23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
Vayyar to provide fall detection powered by touchless technology compatible with new Amazon Alexa Together service
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to…
Vinehealth: $5.5 million of investment to launch in the US
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app…
Women’s Health: WHO launches a chatbot with messaging on breast cancer
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot t…
Pear Therapeutics goes public on Nasdaq as Pear
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the…
PrecisionOS: approved by FDA to market VR surgical planning tool
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administra…
Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-base…
Global Health & Wellbeing Coaching Symposium
Join YourCoach.Health for their second annual Global Health & Wellness Coaching…
Novel algorithm on wearable devices can detect irregular heartbeat, may prompt early care
Research Highlights: A novel software algorithm developed for wearable devices, …